These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 300541)

  • 41. Oxazepam esters. 3. Intrinsic activity, selectivity, and prodrug effect.
    Maksay G; Pálosi E; Tegyey Z; Otvös L
    J Med Chem; 1981 May; 24(5):499-502. PubMed ID: 7241507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic and pharmacodynamic interaction between the antidepressant tianeptine and oxazepam at steady-state.
    Toon S; Holt BL; Langley SJ; Mullins FG; Rowland M; Halliday MS; Salvadori C; Delalleau B
    Psychopharmacology (Berl); 1990; 101(2):226-32. PubMed ID: 2349364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism.
    Sonne J; Boesgaard S; Poulsen HE; Loft S; Hansen JM; Døssing M; Andreasen F
    Br J Clin Pharmacol; 1990 Nov; 30(5):737-42. PubMed ID: 2271373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disposition of oxazepam in relation to age, sex, and cigarette smoking.
    Ochs HR; Greenblatt DJ; Otten H
    Klin Wochenschr; 1981 Aug; 59(16):899-903. PubMed ID: 7278081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic-pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats.
    Dingemanse J; Voskuyl RA; Langemeijer MW; Postel-Westra I; Breimer DD; Meinardi H; Danhof M
    Br J Pharmacol; 1990 Jan; 99(1):53-8. PubMed ID: 2331575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of fluoride in man after single and multiple oral doses.
    Ekstrand J; Alván G; Boréus LO; Norlin A
    Eur J Clin Pharmacol; 1977 Dec; 12(4):311-7. PubMed ID: 590317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of pharmacokinetic interaction between vinpocetine and oxazepam.
    Storm G; Oosterhuis B; Sollie FA; Visscher HW; Sommer W; Beitinger H; Jonkman JH
    Br J Clin Pharmacol; 1994 Aug; 38(2):143-6. PubMed ID: 7981015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flecainide pharmacokinetics in healthy volunteers: the influence of urinary pH.
    Johnston A; Warrington S; Turner P
    Br J Clin Pharmacol; 1985 Oct; 20(4):333-8. PubMed ID: 4074602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HPLC analysis and pharmacokinetics of the enantiomers of R,S-oxazepam and R,S-temazepam with their corresponding glucuronide conjugates in urine and plasma of man.
    Vree TB; Baars AM; Wuis EW
    Acta Neuropsychiatr; 1990 Dec; 2(4):95-100. PubMed ID: 26952555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excretion of oxazepam in breast milk.
    Wretlind M
    Eur J Clin Pharmacol; 1987; 33(2):209-10. PubMed ID: 3691611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of plasma cortisol after oral administration of oxazepam in man.
    Gram LF; Christensen L; Kristensen CB; Kragh-Sorensen P
    Br J Clin Pharmacol; 1984 Feb; 17(2):176-8. PubMed ID: 6704288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Steady-state pharmacokinetics of hydroxychloroquine in rheumatoid arthritis patients.
    Miller DR; Khalil SK; Nygard GA
    DICP; 1991 Dec; 25(12):1302-5. PubMed ID: 1815421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects.
    Chin PK; Jensen BP; Larsen HS; Begg EJ
    Br J Clin Pharmacol; 2011 Dec; 72(6):985-9. PubMed ID: 21671987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placental passage of oxazepam and its metabolism in mother and newborn.
    Tomson G; Lunell NO; Sundwall A; Rane A
    Clin Pharmacol Ther; 1979 Jan; 25(1):74-81. PubMed ID: 758245
    [No Abstract]   [Full Text] [Related]  

  • 55. Differences in diazepam and oxazepam.
    DeVane CL; Stewart RB
    Arch Gen Psychiatry; 1984 Mar; 41(3):311. PubMed ID: 6703851
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of melperon on ocular readaptation time, as assessed by a new recording technique.
    Bergman H; Borg S; Högman B; Larsson H; Tengroth B
    Acta Ophthalmol (Copenh); 1980 Aug; 58(4):632-8. PubMed ID: 7211253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absence of interference of oxazepam with glucose determination.
    Frings CS
    JAMA; 1971 Aug; 217(9):1244. PubMed ID: 5109467
    [No Abstract]   [Full Text] [Related]  

  • 58. Withdrawal reactions after oxazepam.
    Mendelson G
    Lancet; 1978 Mar; 1(8063):565. PubMed ID: 76116
    [No Abstract]   [Full Text] [Related]  

  • 59. What is the point of pharmacokinetics?
    Chamberlain J
    J Pharm Pharmacol; 1994 Dec; 46(12):937. PubMed ID: 7714717
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of clinical and biological parameters in healthy volunteers: more than pharmacokinetics and side effects?
    Puech AJ; Danjou P; Warot D; Bensimon G; Lacomblez L
    Psychopharmacol Ser; 1989; 7():296-302. PubMed ID: 2687865
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.